The role of angiotensin II in hypertension due to adenosine receptors blockade

European Journal of Pharmacology

Volumn 455, Issue 2-3, 2002, Pages 135-141

  Morato, Manuela ^a   Sousa, Teresa ^a   Guimarães, Serafim ^a   Moura, Daniel ^a   Albino Teixeira, António ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Adenosine receptors blockade; Angiotensin II; Hypertension; Vascular reactivity

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; ADENOSINE RECEPTOR BLOCKING AGENT; ANGIOTENSIN; NORADRENALIN; POTASSIUM CHLORIDE; SODIUM CHLORIDE; 1,3-DIPROPYL-8-(4-SULFOPHENYL)XANTHINE; ADENOSINE RECEPTOR; ANGIOTENSIN II; VASOCONSTRICTOR AGENT; XANTHINE DERIVATIVE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG INFUSION; HYPERTENSION; MALE; MESENTERY BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; ANIMAL; BLOOD; BLOOD PRESSURE; DOSE RESPONSE; DRUG ANTAGONISM; IN VITRO STUDY; MESENTERIC ARTERY; MESENTERIC VEIN; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; MALE; MESENTERIC ARTERIES; MESENTERIC VEINS; NOREPINEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; XANTHINES;

EID: 0037195543     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02587-6     Document Type: Article

References (37)

1. Albino-Teixeira A., Matias A., Polónia J., Azevedo I. Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J. Hypertens. 9(Suppl. 6):1991;S196-S197.
2. Boonen H.C., Daemen M.J., Eerdmans P.H., Fazzi G.E., van Kleef E.M., Schiffers P.M., De Mey J.G. Mesenteric small artery changes after vasoconstrictor infusion in young rats. J. Cardiovasc. Pharmacol. 22(3):1993;388-395.
3. Cawley T., Geraghty J., Osborne H., Docherty J.R. Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta. Br. J. Pharmacol. 114:1995;791-796.
4. Collis M.G., Alps B.J. Vascular reactivity to noradrenaline, potassium chloride, and angiotensin II in the rat perfused mesenteric vasculature preparation, during the development of renal hypertension. Cardiovasc. Res. 9:1975;118-126.
5. Day M.D., Moore A.F. Interaction of angiotensin II with noradrenaline and other spasmogens on rabbit isolated aortic atrips. Arch. Int. Pharmacodyn. 219:1976;29-35.
6. Dowell F.J., Henrion D., Benessiano J., Poitevin P., Levy B. Chronic infusion of low-dose angiotensin II potentiates the adrenergic response in vivo. J. Hypertens. 14:1996;177-182.
7. Duckles S.P. Angiotensin II potentiates responses of the rabbit basilar artery to adrenergic nerve stimulation. Life Sci. 28:1981;40-47.
8. Endemann D., Touyz R.M., Li J.-S., Deng L.-Y., Schiffrin E.L. Altered angiotensin II-induced small artery contraction during the development of hypertension in spontaneously hypertensive rats. Am. J. Hypertens. 12:1999;716-723.
9. 1-purinoceptors. J. Auton. Pharm. 16:1996;367-370.
10. Guimarães S., Osswald W. Adrenergic receptors in the veins of the dog. Eur. J. Pharmacol. 5:1969;133-140.
11. 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional level. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;692-695.
12. Guimarães S., Albino-Teixeira A., Paiva M.Q. Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors. Br. J. Pharmacol. 114(8):1995;1595-1598.
13. Haefliger J.-A., Bergonzelli G., Waeber G., Aubert J.-F., Nussberger J., Gavras H., Nicod P., Waeber B. Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats. Hypertension. 26(5):1995;733-737.
14. Hayakawa H., Raji L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension. 29(Part 2):1997;235-241.
15. 2+ influx: role of protein kinase C. J. Pharmacol. Exp. Ther. 261:1992;835-842.
16. Henrion D., Laher I., Laporte R., Bevan J.A. Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase C. Eur. J. Pharmacol. 225:1992;13-20.
17. Holycross B.J., Jackson E.K. Adenosine-angiotensin II interactions: Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction. J. Pharmacol. Exp. Ther. 250(2):1989;433-441.
18. Hoshino J., Sakamaki T., Nakamura T., Kobayashi M., Kato M., Sakamoto H., Kurashina T., Yagi A., Sato K., Ono Z. Exaggerated vascular response due to endothelial dysfunction and role of the renin-angiotensin system at early stage of renal hypertension in rats. Circ. Res. 74:1994;130-138.
19. Jackson E.K. Adenosine: a physiological brake on renine release. Annu. Rev. Pharmacol. Toxicol. 31:1991;1-35.
20. Karoon P., Rubino A., Burnstock G. Enhanced sympathetic neurotransmission in the tail artery of 1,3-dipropyl-8-sulfophenylxanthine (DPSPX)-treated rats. Br. J. Pharmacol. 116(2):1995;1918-1922.
21. Konishi C., Naito Y., Saito Y., Ohara N., Ono H. Age-related differences and roles of endothelial nitric oxide and prostanoids in angiotensin II responses of isolated, perfused mesenteric arteries and veins of rats. Eur. J. Pharmacol. 320:1997;175-181.
22. Laragh J.H., Baer L., Brunner H.R., Buhler F.R., Sealey J.E., Vaughan E.D. Jr. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am. J. Med. 52:1972;633-652.
23. McCubbin J.W., DeMoura R.S., Page I.H., Olmsted F. Arterial hypertension elicited by subpressure amounts of angiotensin. Science. 149:1965;1394-1395.
24. Morato M., Sousa T., Guimarães S., Moura D., Albino-Teixeira A. Antihypertensive effects of losartan and atenolol on 1,3-dipropyl-8-sulfophenylxanthine (DPSPX)-induced hypertension. Br. J. Pharmacol. 135(Suppl.):2002;P125.
25. Moreno L., Martínez-Cuesta M.A., Piqué J.M., Bosch J., Esplugues J.V. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;474-480.
26. Nishida Y., Ding J., Zhou M.-S., Chen Q.-H., Murakami H., Wu X.-Z., Kosaka H. Role of nitric oxide in vascular hyper-responsiveness to norepinephrine in hypertensive Dahl rats. J. Hypertens. 16:1998;1611-1618.
27. Paiva M.Q., Santos M.J., Albino-Teixeira A. Endothelium-dependent vascular responses in 1,3-dipropyl-8-sulfophenylxanthine (DPSPX)-hypertensive rats. J. Pharm. Pharmacol. 49(1):1997;74-77.
28. Qiu H.Y., Henrion D., Levy B.I. Endogenous angiotensin II enhances phenylephrine-induced tone in hypertensive rats. Hypertension. 24(3):1994;317-321.
29. 1-purinoceptor antagonist, DPSPX. Br. J. Pharmacol. 118:1996;1675-1680.
30. Rubino A., Burnstock G. Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension. J. Pharmacol. Exp. Ther. 275:1995;422-428.
31. Saino A., Pomidossi G., Perondi R., Valentini R., Rimini A., Di Francesco L., Mancia G. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans. Circulation. 96:1997;148-153.
32. Sitzmann J.V., Li S.S., Wu Y.P., Groszmann R., Bulkley G.B. Decreased mesenteric vascular response to angiotensin II in portal hypertension. J. Surg. Res. 48(4):1990;341-344.
33. Sousa T., Morato M., Albino-Teixeira A. Angiotensin-converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors. Eur. J. Pharmacol. 441(1-2):2002;99-104.
34. Tschudi M.R., Lüscher T.F. Age and hypertension differently affect coronary contractions to endothelin-1, serotonin, and angiotensins. Circulation. 91:1995;2415-2422.
35. Vanhoutte P.M., Verbeuren T.J., Webb R.C. Local modulation of adrenergic neuroeffector interaction in the blood vessel wall. Physiol. Rev. 61:1981;151-159.
36. Warner T. Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists. Br. J. Pharmacol. 99:1990;427-433.
37. Weber M.A., Purdy R.E., Stupecky G.L., Prins B.A. Augmentation of sympathomimetic arterial contraction by angiotensin II: a novel mechanism. J. Vasc. Med. Biol. 1:1989;7-15.